LactaLogics
LactaLogics is a Florida-based nutrition company developing shelf-stable, 100% human milk-based products — including donor milk and fortifiers — using proprietary Gentle-UHT processing for hospital NICUs and outpatient families caring for premature and at-risk infants.
- Company typePrivate
- Founded2014
- HeadquartersPort St. Lucie, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What LactaLogics does
LactaLogics is a privately held human milk-based nutrition company headquartered in Port St. Lucie, Florida, founded in 2014 (originally as International Milk Bank, rebranded in 2020). The company develops and intends to commercialize a portfolio of 100% human milk-based products — donor human milk, human milk-based fortifier (available in standardized 18 and 20 calorie options), and BridgePacks — for premature and at-risk infants in hospital NICUs and, on a planned basis, in outpatient home-use settings. Its core innovation is the proprietary Gentle-UHT process: indirect ultra-high temperature pasteurization paired with bactofugation and light homogenization, validated across more than 50 R&D and commercial-scale runs at Tetra Pak's pilot facility in Denton, Texas. The technology achieves over a 1,000 log reduction of Bacillus cereus spores while retaining more than 90% of proteins, immune factors, and HMOs, producing shelf-stable human milk that does not require freezing or thawing. Aseptic packaging is delivered through a partnership with Scholle IPN.
The company's revenue model centers on direct hospital procurement of human milk-based fortifiers and ready-to-feed donor milk for NICUs, with a future physician-prescribed outpatient/home-use channel and a Donor Success Program that supplies raw milk through a screened donor network compensated via Fast-Reimburse within two weeks. The GTM is enterprise field sales targeting neonatologists, NICU nurses, lactation consultants, and hospital procurement teams. As of early 2026, LactaLogics is pre-commercial at scale: a 72,000 sq ft processing facility in Port St. Lucie is at 95% completion with production scheduled for the first half of 2026 and planned annual capacity of 60 million ounces, against an estimated U.S. market need of more than 100 million ounces annually. The company closed over $92 million in financing in March 2024 (USDA Food Safety Loan via Magnolia Bank, DOE CPACE Loan via PACE Equity, state and local government support, and private capital from McCarvill Capital Partners) to fund facility construction. Headcount is 11-50 and revenue is not publicly disclosed.
LactaLogics firmographics
Firmographics- Name
- LactaLogics
- Legal name
- LactaLogics, Inc.
- Website
- https://lactalogics.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LactaLogics is a Florida-based nutrition company developing shelf-stable, 100% human milk-based products — including donor milk and fortifiers — using proprietary Gentle-UHT processing for hospital NICUs and outpatient families caring for premature and at-risk infants.
- Ownership category
- akta.pro rank
LactaLogics industry classification
Industry- Product category
- Neonatal Nutrition Products
- NAICS
- Dairy Product (except Frozen) Manufacturing (31151), Fluid Milk Manufacturing (311511)
- SIC
- Dairy Products (2020)
- akta.pro primary industry
- Infant Formula & Specialized Dairy Nutrition Manufacturing (AFAKAKAJ)
- akta.pro secondary industries
- UHT/Aseptic Fluid Milk Processing (AFAHAAAD), Milk (Fluid & Shelf-Stable) (CRADACAA)
Keywords
Where LactaLogics is headquartered
LocationHeadquarters
- HQ city
- Port St. Lucie
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
LactaLogics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Infrastructure, Technology or R&D, Supply Chain, Operations, Marketing or Sales
Revenue model
- Human Milk-Based Fortifier Sales: LactaLogics sells 100% human milk-based fortifier products to hospital NICUs. The fortifier works in partnership with mom's milk to deliver concentrated nutrition premature infants need. Products are available in standardized calorie and protein content options (18 and 20 calorie products). Revenue is generated through direct hospital procurement contracts.
- Ready-to-Feed Donor Human Milk: Shelf-stable, aseptically packaged donor human milk sold to hospitals and families for use in NICUs and home care settings. Distributed via clinical channels with physician involvement. The product addresses supplementation gaps for both premature and full-term infants.
- Donor Program Services: LactaLogics operates a donor support program connecting milk donors with infants in need. Donors receive reimbursement through the company's Fast-Reimburse Program. The program supports the company's raw material supply chain for processing.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
LactaLogics product offering
Product offeringCore offering
LactaLogics develops and produces 100% human milk-based nutritional products, including shelf-stable donor human milk and human milk-based fortifiers, processed through its proprietary Gentle-UHT indirect ultra-high temperature pasteurization platform combined with bactofugation and light homogenization. The products are sold primarily to hospital NICUs for premature and at-risk infants, with planned outpatient distribution to families via physician prescription.
Product overview
LactaLogics is a human milk-based nutrition company offering a portfolio of 100% human milk-based products designed to support premature and at-risk infants from the NICU to at-home care. The core product portfolio includes Donor Human Milk (shelf-stable, processed via Gentle-UHT), Human Milk-Based Fortifier (works with mother's milk), and BridgePacks (outpatient supplement alternative to formula). All products utilize the proprietary Gentle-UHT processing technology which enables superior protein retention while ensuring safety through indirect heat treatment, resulting in products that can be stored at room temperature without refrigeration.
Differentiator
Problem solved
Functional benefit
Products and services
- Donor Human Milk
Quantifiable outcome
- 93% of infants successfully transitioned from donor human milk supplementation to exclusive breastfeeding in a pilot study
- +5 more outcomes
Companies that use LactaLogics
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
LactaLogics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
LactaLogics partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Dennis GroupcoreDennis Group is the award-winning design-builder contracted for the construction of LactaLogics' 70,000-square-foot human milk processing facility in Port St. Lucie, Florida. The firm is dedicated to delivering a world-class facility that meets the highest food safety standards while supporting the unique requirements of human milk processing.
- NEC SocietyminorLactaLogics serves as a 2022 Champion for the NEC Society, a non-profit dedicated to creating a world without necrotizing enterocolitis. As a Champion, LactaLogics helps drive research, education, and advocacy for premature and medically vulnerable infants at risk of NEC — the leading cause of morbidity and mortality in the NICU.
- Scholle IPNcoreScholle IPN is a global flexible packaging manufacturer specializing in aseptic packaging technology. The partnership gives hospitals access to pharmaceutical-grade aseptic packaging technology that does not require refrigeration and minimizes open-air mixing, revolutionizing how human milk is administered in NICU settings. LactaLogics' human milk-based products are packaged in aseptic pouches and cartons.
- Tetra PakcoreTetra Pak, a Sweden-based world-leading food processing and packaging solutions company, completed engineering work with LactaLogics for large-scale manufacturing. LactaLogics conducted three commercial-grade processing runs at Tetra Pak's Denton, Texas Product Development Center prior to finalizing the engineering agreement. The partnership validates LactaLogics' approach for aseptic processing and all parts of large-scale manufacturing, positioning the company to produce 60 million ounces of human milk-based products per year.
Scale indicators11 records
Recent moves8 records
Expansion highlights7 records
LactaLogics competitors and assessment
Company assessmentDirect peers
- Prolacta Bioscience: Prolacta is the dominant US producer of 100% human milk-based fortifiers and standardized donor milk for NICUs, competing head-to-head with LactaLogics in the same hospital channel with the same product category. Its former Chief Medical and Scientific Officer (Dr. Victoria Niklas) now sits on LactaLogics' board, underscoring how directly the two companies compete.
- Medolac Laboratories: Medolac is a US-based human milk biopharmaceutical company producing shelf-stable donor human milk products for hospital and clinical use. It competes with LactaLogics in the same donor-milk, NICU-focused category and similarly targets improvements over traditional Holder pasteurization.
Emerging players
- NeoKare: NeoKare is a UK-based human milk processor producing pasteurized donor human milk and related neonatal nutritional products for hospital use. It is an emerging player in the same product category with overlapping technology goals (improved processing of human milk for preterm infants) but serves primarily European hospitals.
- Bobbie: Bobbie is a US-based organic infant formula startup focused on the direct-to-consumer and outpatient channel, where LactaLogics plans to compete with its BridgePack home-use line. While Bobbie is bovine-based rather than human-milk-based, it competes for the same supplementation and feeding-decision use cases among new parents.
Broad incumbents
- Mead Johnson Nutrition (Reckitt): Mead Johnson, owner of the Enfamil brand, is a global incumbent in infant formula and pediatric nutrition sold into the same hospital NICU and outpatient channels that LactaLogics targets. While its products are bovine-based rather than human-milk-based, it competes for the same feeding-decision wallet share in NICUs and at home.
- Abbott Nutrition: Abbott's Similac brand is a leading infant formula sold into US hospital NICUs and retail, directly competing for the nutritional decision LactaLogics targets with its donor human milk and fortifier. Abbott is a broad incumbent across the full neonatal nutrition category, including specialty formulas for preterm infants.
- Nestlé Health Science: Nestlé Health Science offers infant formula, preterm nutrition, and pediatric medical nutrition products sold into hospital and outpatient channels globally. It competes for neonatal nutritional decisions alongside LactaLogics and could expand into human milk-based offerings over time.
- Danone Nutricia: Danone's Nutricia division is a global leader in early-life nutrition, including preterm and specialty infant formulas sold into hospital NICUs and through retail. It is a broad incumbent competing for the same feeding decisions as LactaLogics, particularly in Europe.
- Perrigo Nutritionals: Perrigo manufactures store-brand and specialty infant formulas distributed through US hospitals and retail, competing in the same preterm and full-term infant feeding decisions as LactaLogics. It is a broad incumbent in pediatric nutrition with established hospital relationships.
Others
- Human Milk Banking Association of North America (HMBANA) member banks: HMBANA is a network of nonprofit donor human milk banks that supply pasteurized human milk to US hospitals. They are not direct commercial peers but represent the traditional supply channel LactaLogics is competing with and potentially displacing through shelf-stable, scalable manufacturing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
LactaLogics social profiles
Digital presenceLactaLogics financial estimates
Financial estimateRevenue estimate
Valuation estimate
LactaLogics leadership team
Management profileNumber of profiles
Profiles14 records
LactaLogics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LactaLogics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LactaLogics
What does LactaLogics do?
LactaLogics develops and produces 100% human milk-based nutritional products, including shelf-stable donor human milk and human milk-based fortifiers, processed through its proprietary Gentle-UHT indirect ultra-high temperature pasteurization platform combined with bactofugation and light homogenization. The products are sold primarily to hospital NICUs for premature and at-risk infants, with planned outpatient distribution to families via physician prescription.
Is LactaLogics a public or private company?
LactaLogics is a private company. It is classified as venture growth investor backed and is currently operating.
When was LactaLogics founded?
LactaLogics was founded in 2014. It employs 11 to 50 people.
Where is LactaLogics based?
LactaLogics is headquartered in Port St. Lucie, United States, in the North America region.
How does LactaLogics make money?
Three revenue lines are on record. Human Milk-Based Fortifier Sales are the primary driver. The others are ready-to-Feed Donor Human Milk and donor Program Services.
Who are LactaLogics's main competitors?
Direct peers on record are Prolacta Bioscience and Medolac Laboratories. Emerging players are NeoKare and Bobbie. Broad incumbents are Mead Johnson Nutrition (Reckitt), Abbott Nutrition, Nestlé Health Science, Danone Nutricia and Perrigo Nutritionals. Human Milk Banking Association of North America (HMBANA) member banks is listed as an others.
Does LactaLogics have an API?
No public API is recorded for LactaLogics.
What industry is LactaLogics in?
LactaLogics's product category is Neonatal Nutrition Products. Its primary akta.pro industry code is AFAKAKAJ, Infant Formula & Specialized Dairy Nutrition Manufacturing, with a secondary code of AFAHAAAD, UHT/Aseptic Fluid Milk Processing. Its NAICS code is 31151 and its SIC code is 2020.